iCAD, Inc. ICAD
3.87 0.00 (+0.00%)
At closeJul 17, 2025, 4:00 PM EDT
3.87 Day range 3.87
1.18 52-week range 2.65
- YTD
- +111.48%
- 1 year
- +182.48%
- Market cap
- 44.41M
- Revenue (ttm)
- 18.80M
- Profit margin
- -12.13%
- EPS (ttm)
- -0.20
- Shares out
- 26.35M
- Forward P/E
- -8.02
- YTD return
- +111.48%
- 1-year return
- +182.48%
- Volume
- 190.13K
- Avg volume
- 252.54K
- Open
- 3.87
- Previous close
- 3.87
- Day's range
- 3.87 – 3.87
- 52-week range
- 1.18 – 2.65
- Beta
- 1.48
- Price target
- 4.38 (+13.0%)
2Y +0.28 (+7.80%)
Key statistics
- Enterprise value
- 27.16M
- PEG ratio
- 0.00
- Price / sales
- 2.36
- Price / book
- 1.33
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 20.60%
- Free cash flow
- -2.94M
- Total cash
- 20.35M
- Total debt
- 469.00K
- Return on equity
- -14.86%
- Short % of float
- 0.96%
- 50-day average
- 1.80
- 200-day average
- 1.58
Analyst view
Price target (mean) 4.38 +13.0% upside
Now 3.87
- Target (low)
- 2.50
- Target (mean)
- 4.38
- Target (high)
- 9.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.06.
Financials — quick view
ICAD Revenue — quarterly 4.87M
ICAD Net income — quarterly -833.00K
ICAD EPS — quarterly -0.03
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -0.07 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.07 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -0.05 | — | — |
| Mar 12, 2024 | Dec 1, 2023 | 0.00 | -0.02 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -0.04 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -0.07 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 19, 2023 | Lake Street | main | Buy | Buy |
| Apr 13, 2023 | JMP Securities | main | — | Outperform |
| Apr 4, 2023 | Oppenheimer | main | — | Outperform |
| Mar 29, 2023 | BTIG | main | — | Buy |
| Mar 29, 2023 | Lake Street | main | — | Buy |
| Sep 1, 2022 | JMP Securities | main | — | Market Outperform |
About iCAD, Inc.
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- icadmed.com
News
ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD 
iCAD Reports Financial Results for First Quarter Ended March 31, 2025 
ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD 
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of iCAD, Inc. - ICAD 
12 Health Care Stocks Moving In Wednesday's Intraday Session 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket 
ICAD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iCad, Inc. Is Fair to Shareholders 
12 Health Care Stocks Moving In Tuesday's After-Market Session 
iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer
Your note
Sign in to keep a note on ICAD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN DANA R | Chief Executive Officer | Purchase | Mar 30, 2023 | 40,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 4.27% | 1,132,658 | 1.91M | Sep 29, 2024 |
| First Eagle Investment Management, LLC | 2.54% | 675,161 | 1.14M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 2.27% | 601,290 | 1.01M | Sep 29, 2024 |
| Blackrock Inc. | 1.32% | 351,617 | 592.47K | Sep 29, 2024 |
| AMH Equity Ltd. | 1.12% | 296,052 | 498.85K | Sep 29, 2024 |
| Greenwood Capital Associates, Inc. | 1.11% | 295,147 | 497.32K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.91% | 771,983 | 1.30M | Sep 29, 2024 |
| First Eagle Small Opportunity Fund | 2.40% | 637,491 | 1.07M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 1.20% | 319,228 | 537.90K | Sep 29, 2024 |
| General American Investors Co | 0.76% | 200,434 | 337.73K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.54% | 143,159 | 241.22K | Oct 30, 2024 |
| Perritt Microcap Opportunities Fund | 0.45% | 119,000 | 200.51K | Sep 29, 2024 |